| Anthony T Johnson, MD | |
|
102 Mandan Ave, Mandan, ND 58554-3771 | |
| (701) 667-5000 | |
| (701) 323-5709 |
| Full Name | Anthony T Johnson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 102 Mandan Ave, Mandan, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912918772 | NPI | - | NPPES |
| 18610 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 7321 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Home Care | Mandan, ND | Home health agency |
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Bismarck | 9739098575 | 448 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.
The latest research findings suggest that when assessing the risk of heart problems, offering statins or drugs that lower cholesterol to all over-55s had the same results as testing for cholesterol or blood pressure problems. The authors have also argued it would be simpler and more cost effective.
Amanda Botticello, PhD, MPH, research scientist in Outcomes & Assessment Research at Kessler Foundation, received a National Institutes of Health (NIH) grant to study the role of environmental factors in rehabilitation outcomes in spinal cord injury.
GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted.
› Verified 9 days ago
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.
The latest research findings suggest that when assessing the risk of heart problems, offering statins or drugs that lower cholesterol to all over-55s had the same results as testing for cholesterol or blood pressure problems. The authors have also argued it would be simpler and more cost effective.
Amanda Botticello, PhD, MPH, research scientist in Outcomes & Assessment Research at Kessler Foundation, received a National Institutes of Health (NIH) grant to study the role of environmental factors in rehabilitation outcomes in spinal cord injury.
GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony T Johnson, MD Po Box 5501, Bismarck, ND 58506-5501 Ph: (701) 323-6000 | Anthony T Johnson, MD 102 Mandan Ave, Mandan, ND 58554-3771 Ph: (701) 667-5000 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.
The latest research findings suggest that when assessing the risk of heart problems, offering statins or drugs that lower cholesterol to all over-55s had the same results as testing for cholesterol or blood pressure problems. The authors have also argued it would be simpler and more cost effective.
Amanda Botticello, PhD, MPH, research scientist in Outcomes & Assessment Research at Kessler Foundation, received a National Institutes of Health (NIH) grant to study the role of environmental factors in rehabilitation outcomes in spinal cord injury.
GlaxoSmithKline is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs), such as GSK's Advair (salmeterol / fluticasone propionate). GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted.
› Verified 9 days ago
Meghan Hendrickson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Mandan Ave, Mandan, ND 58554 Phone: 701-323-6000 | |
Boyd F Addy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2008 Twin City Dr, Mandan, ND 58554 Phone: 701-667-1000 Fax: 701-667-0707 | |
Dale A Klein, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-323-5709 | |
Laura Archuleta, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Sunset Drive Nw, Mandan, ND 58554 Phone: 701-667-4600 Fax: 701-530-3780 | |
Andrew Dockter, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 | |
Sadaf Yousuf, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-667-5095 | |
Gretchen G Belzer-curl, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 18th St Nw, Mandan, ND 58554 Phone: 701-667-5100 Fax: 701-667-5095 |